Braze Inc vs Cassava Sciences Inc — how do they compare? Braze Inc trades at $28.05 (market cap $3.18B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Braze Inc is far larger — about 66.6× Cassava Sciences Inc's market cap, and Braze Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| BRZE | FLNA | |
|---|---|---|
Market Cap | $3.18B | $47.75M |
Sector | Technology | Health |
52-Week High | $36.19 | $4.64 |
52-Week Low | $15.79 | $0.87 |
Enterprise Value | $2.87B | -$34.93M |
Trailing returns across standard periods
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →